Low HR positive breast cancer
Podcast 2021029
Questions:
- Can You explain what is meant by the title „low positive“ luminal breast cancer?
- Is that treshold (<10%) uniform everywhere, in the entire oncology /pathology/ community?
- What are the guidelines to follow on this question?
- Can You comment on the two tresholds for defining positive HR status (≥1% vs ≥10%)?
- Is there an implication on therapeutic approach (i.e. how should we be treating these cases, should they receive ET)? Please explain.
Expert
/attachment.e-eso.net%2F48%2F2021021012280381.JPG)
Pathologist
National Cancer Institute, IRCCS Foundation
Milan, Italy
National Cancer Institute, IRCCS Foundation
Milan, Italy
28
Oct 2021
